학술논문

Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours
Document Type
Article
Source
In ESMO Open June 2021 6(3)
Subject
Language
ISSN
2059-7029